These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 8184570

  • 1. [Is it possible to predict a decrease in portal pressure after administration of ACE inhibitors?].
    Svoboda P, Kantorová I, Ochmann J.
    Vnitr Lek; 1994 Mar; 40(3):170-3. PubMed ID: 8184570
    [Abstract] [Full Text] [Related]

  • 2. Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension.
    Svoboda P, Ochmann J, Kantorová I.
    Hepatogastroenterology; 1992 Dec; 39(6):549-52. PubMed ID: 1336475
    [Abstract] [Full Text] [Related]

  • 3. [The ACE inhibitor, enalapril, in portal hypertension. A prospective placebo controlled study].
    Svoboda P, Ochmann J, Kantorová I, Sefr R.
    Cas Lek Cesk; 1992 Mar 27; 131(6):170-3. PubMed ID: 1586932
    [Abstract] [Full Text] [Related]

  • 4. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ.
    J Gastroenterol; 2003 Mar 27; 38(12):1150-4. PubMed ID: 14714252
    [Abstract] [Full Text] [Related]

  • 5. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1993 Nov 27; 18(5):1082-9. PubMed ID: 8225212
    [Abstract] [Full Text] [Related]

  • 6. Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril.
    Ziai SA, Seyedhosseini D, Taiebi L, Salekmoghadam E, Mahmoudian M.
    Acta Physiol Hung; 2000 Nov 27; 87(2):153-9. PubMed ID: 11205963
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M, Miszputen SJ, Leite-mor MM, Parise ER.
    Hepatogastroenterology; 1995 Nov 27; 42(5):542-5. PubMed ID: 8751212
    [Abstract] [Full Text] [Related]

  • 8. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z, Feng H, Leng X, Ma F, Wang B, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Jun 27; 37(6):366-8. PubMed ID: 11829864
    [Abstract] [Full Text] [Related]

  • 9. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, Mandal SK, Ray S, Dasgupta S.
    Am J Gastroenterol; 2003 Jun 27; 98(6):1371-6. PubMed ID: 12818283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May 27; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics.
    Pereira-Lima JC, Zanette M, Lopes CV, de Mattos AA.
    Hepatogastroenterology; 2003 May 27; 50(49):102-6. PubMed ID: 12630002
    [Abstract] [Full Text] [Related]

  • 15. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 27; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 16. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G, Letizia C, Domenici A, Scavo D.
    Drugs Exp Clin Res; 1991 Dec 27; 17(5):263-9. PubMed ID: 1661665
    [Abstract] [Full Text] [Related]

  • 17. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L, Rodado R, Barrios Y, Campos M, Llorente S, Nicolas F, Minguela A.
    Transplant Proc; 2005 Mar 27; 37(2):1012-3. PubMed ID: 15848608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 27; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.